Virulence Factor, iceA

Optimal result: 0 – 0.0001 Units

The presence of the iceA gene as positive on a GI-Map panel indicates the detection of a virulence factor associated with Helicobacter pylori, a type of bacteria that can infect the stomach. There are two main types of the iceA gene: iceA1 and iceA2. The iceA gene is involved in the pathogenesis of H. pylori, meaning it plays a role in how the bacterium causes disease.

H. pylori infection is a major cause of peptic ulcers and it has been associated with the development of gastric cancer and mucosa-associated lymphoid tissue (MALT) lymphoma. The iceA1 variant, in particular, has been associated with an increased risk of gastric mucosal inflammation and ulceration.

However, the presence of the iceA gene alone, without clinical symptoms or other diagnostic markers, may not be sufficient to diagnose an H. pylori infection or to predict disease outcome. It's part of a broader diagnostic approach that includes assessing symptoms, other laboratory tests, and possibly endoscopic examination.

If the GI-Map panel indicates that iceA is positive, it suggests that there may be an active H. pylori infection that could contribute to gastrointestinal symptoms or conditions. Treatment for H. pylori infection typically involves a combination of antibiotics and medications to reduce stomach acid and protect the stomach lining. It's important to consult with a healthcare provider for a comprehensive evaluation and appropriate treatment if H. pylori infection is suspected.

The iceA gene is recognized as a significant virulence factor in the genome of Helicobacter pylori, a Gram-negative, spiral-shaped bacterium implicated in the pathogenesis of various gastrointestinal diseases, including gastritis, peptic ulcers, and is associated with the development of gastric cancer. This gene exists in two main allelic variants: iceA1 and iceA2, each displaying different epidemiological distributions and potential roles in the bacterium's pathogenicity.

The iceA gene is recognized as a significant virulence factor in the genome of Helicobacter pylori, a Gram-negative, spiral-shaped bacterium implicated in the pathogenesis of various gastrointestinal diseases, including gastritis, peptic ulcers, and is associated with the development of gastric cancer. This gene exists in two main allelic variants: iceA1 and iceA2, each displaying different epidemiological distributions and potential roles in the bacterium's pathogenicity. The iceA1 allele has been more closely associated with gastric mucosal damage and ulcer formation, suggesting a more direct involvement in the bacterium's virulence mechanisms. The exact function of the iceA gene remains not fully elucidated, but it is hypothesized to influence the bacterium's ability to interact with the gastric epithelium, possibly through modulation of the host's immune response or by affecting the bacterium's adhesion properties. The presence of the iceA gene, particularly the iceA1 variant, in H. pylori strains has been correlated with increased inflammatory responses and a higher risk of developing more severe gastric diseases. However, the clinical relevance of iceA gene detection in H. pylori infections is still under investigation, as the pathogenesis of H. pylori-related diseases is multifactorial and involves a complex interplay of bacterial, host, and environmental factors. Consequently, the identification of the iceA gene in clinical isolates of H. pylori, through molecular diagnostic panels such as the GI-Map, provides valuable insights into the potential virulence and pathogenic capacity of the infecting strain, thereby informing therapeutic strategies and clinical management of the infection.

Virulence Factor, iceA
Healthmatters dashboard showing biomarker trend graph

Every lab result you’ve ever had, charted and explained.

Healthmatters is a tracker for your lab results. Upload a report from any lab, any country — every marker charted and explained.

Start with my report →
Beyond Virulence Factor, iceA — 10,000+ markers explained
One Virulence Factor, iceA result tells you where you are. Your history tells you where you’re heading. Upload your past lab reports and see this marker — and every marker on them —every marker charted against your own lab’s ranges.
Start with this report →
Healthmatters timeline preview showing biomarker trends over time
Clinical Sources & References

All our content is backed by peer-reviewed studies, academic research, and trusted medical sources. We’re committed to accuracy and transparency — see our editorial policy for details.

Article Review Log
Written by Healthmatters Editorial Team
Healthmatters Lifetime Plan

Pay $250. Track your health forever

One payment. No renewals. Yours for life.

10,000+ biomarkers explained · trends over time

See other plans →
Secure checkout via Stripe · GDPR & HIPAA
We accept results from any lab
LabCorp Quest Diagnostics Genova Diagnostics DUTCH Test Doctor's Data Vibrant America ZRT Laboratory Cyrex Labs + any other lab

What members are saying

★★★★★ 10,000+ happy members
★★★★★

"Watching my numbers move over the years — instead of forgetting last time's results — completely changed how I manage my health."

Daniel
Member since 2022
★★★★★

"Living across several countries made keeping my lab results organized a real challenge. Healthmatters brought my results from the USA, Spain, and Germany together — 20 years of history, with long-term trends instead of scattered reports."

Ben
Member since 2021 · tracks across countries
★★★★★

"Standard lab ranges are too wide for how I practice — 'normal' isn't optimal. I set my own bands, so a client sees yellow before a marker goes officially out of range. That's the conversation I want to be having."

Dr. Alexandra
Functional medicine · 6 yrs on Pro